Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of antibiotic treatment on clinical outcomes in patients with COVID-19: a systematic review and meta-analysis.

The Lancet. Microbe·2026
Same author

Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.

The Lancet. Infectious diseases·2026
Same author

Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional study.

Cell reports·2026
Same author

An automated and portable platform for rapid cell-free DNA isolation and its application in microbial DNA metagenomic sequencing from human blood samples.

Lab on a chip·2026
Same author

Perspectives on multimorbidity care provision among public hospital-based healthcare workers in Blantyre and Chiradzulu, Malawi: A qualitative study.

PloS one·2026
Same author

Summary of WHO clinical practice guidelines for influenza.

BMJ (Clinical research ed.)·2026

Related Experiment Video

Updated: Jun 7, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

Priorities for tuberculosis research: a systematic review.

Jamie Rylance1, Madhukar Pai, Christian Lienhardt

  • 1Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi. jrylance@liv.ac.uk

The Lancet. Infectious Diseases
|November 6, 2010
PubMed
Summary
This summary is machine-generated.

This study reviewed tuberculosis research priorities, finding drug development and diagnostics as key areas. Future priority setting should be more rigorous and transparent, building on existing knowledge for better tuberculosis control.

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Related Experiment Videos

Last Updated: Jun 7, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Area of Science:

  • Public Health
  • Infectious Diseases
  • Medical Research

Background:

  • Effective tuberculosis control relies on robust and relevant research.
  • Numerous organizations have identified and prioritized tuberculosis research needs.
  • A comprehensive summary and methodological assessment of these priorities is lacking.

Purpose of the Study:

  • To summarize existing priority statements for tuberculosis research.
  • To critically assess the rigor and transparency of the methods used to establish these priorities.
  • To identify key research areas and focused questions within tuberculosis research.

Main Methods:

  • Systematic review of documents outlining tuberculosis research priorities.
  • Analysis of 33 identified priority-setting documents.
  • Categorization of priorities into key research areas.

Main Results:

  • Top priority areas include drug development, diagnostics, epidemiology, health services research, basic research, and vaccine development.
  • Specific focus exists on multidrug-resistant tuberculosis and HIV co-infection.
  • Methods for priority setting were diverse, with room for improvement in rigor and transparency.

Conclusions:

  • Existing tuberculosis research priorities highlight critical areas like drug development and diagnostics.
  • Methodological improvements in priority-setting processes are needed for greater rigor and transparency.
  • Adopting an incremental approach to priority development, leveraging existing evidence, is recommended for organizations like WHO and the Stop TB Partnership.